Author

C. Pantelidou

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

G. I. Shapiro· 2 shared A. D. D'Andrea· 1 shared A. Farkkila· 1 shared A. Kothari· 1 shared A. Li· 1 shared A. Syed· 1 shared B. Kochupurakkal· 1 shared B. S. Blagg· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. I. Shapiro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJan 26, 2021

STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer

C. Pantelidou, H. Jadhav, A. Kothari…·G. I. Shapiro

DOI 10.1038/s41523-022-00471-5

𝕏 PostBluesky

Cancer BiologybioRxivMay 23, 2020

Polymerase Theta Inhibition Kills Homologous Recombination Deficient Tumors

J. Zhou, C. Gelot, C. Pantelidou…·A. D. D'Andrea

The paper identifies Novobiocin as a POLθ inhibitor that selectively kills HR-deficient tumors, including those resistant to PARP inhibitors.

DOI 10.1038/s43018-021-00203-x

humanexperimental assay

𝕏 PostBluesky